Drug Type siRNA |
Synonyms- |
Target |
Action inhibitors |
Mechanism GPR75 inhibitors(G protein-coupled receptor 75 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiovascular Diseases | Preclinical | China | 14 Nov 2025 | |
| Diabetes Mellitus | Preclinical | China | 14 Nov 2025 | |
| Fatty Liver | Preclinical | China | 14 Nov 2025 | |
| Neoplasms | Preclinical | China | 14 Nov 2025 | |
| Obesity | Preclinical | China | 14 Nov 2025 |





